K. M. Matkuliev, U. Khasanov, G.A. Rakhimjonova, S. Bakieva, N. Abdullaeva
{"title":"MORPHOLOGICAL RESULTS WITH THE APPLICATION OF A XENOGRAFT IN EXPERIMENTAL TYMPANOPLASTY","authors":"K. M. Matkuliev, U. Khasanov, G.A. Rakhimjonova, S. Bakieva, N. Abdullaeva","doi":"10.37547/ijmscr/volume03issue04-14","DOIUrl":null,"url":null,"abstract":"To date, there is no consensus on the question of which tissues are more appropriate to use for tympanic membrane plastic surgery. We decided to study the use of xenograft from sheep pericardium in tympanoplasty in rabbits in an experiment with chronic dry mesotympanitis. Experimental morphological studies using a xenograft were carried out in 28 rabbits. In the experiment, a positive result was obtained in 25 (89.3%), negative in 3 (10.7%) rabbits.","PeriodicalId":297181,"journal":{"name":"International Journal of Medical Sciences And Clinical Research","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Medical Sciences And Clinical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37547/ijmscr/volume03issue04-14","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
To date, there is no consensus on the question of which tissues are more appropriate to use for tympanic membrane plastic surgery. We decided to study the use of xenograft from sheep pericardium in tympanoplasty in rabbits in an experiment with chronic dry mesotympanitis. Experimental morphological studies using a xenograft were carried out in 28 rabbits. In the experiment, a positive result was obtained in 25 (89.3%), negative in 3 (10.7%) rabbits.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
